[Modern molecular approaches to diagnosis and treatment of high-grade brain gliomas].

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Voprosy neirokhirurgii imeni N N Burdenko

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.17116/neiro201478685-100PMID 25874291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA-650 expression in glioma is associated with prognosis of patients

  2013cited by this paper
• MicroRNA‐203 down‐regulation is associated with unfavorable prognosis in human glioma

  2013cited by this paper
• Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model

  2013cited by this paper
• Contribution of microRNAs to radio- and chemoresistance of brain tumors and their therapeutic potential.

  2012cited by this paper
• Epidemiology of glial and non-glial brain tumours in Europe.

  2012cited by this paper
• Pathological significance of epidermal growth factor receptor expression and amplification in human gliomas

  2012cited by this paper
• Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol

  2012cited by this paper
• The expression of calcitonin receptor detected in malignant cells of the brain tumour glioblastoma multiforme and functional properties in the cell line A172

  2012cited by this paper
• Targeted delivery of liposomal nanocontainers to the peritumoral zone of glioma by means of monoclonal antibodies against GFAP and the extracellular loop of Cx43.

  2012cited by this paper
• ["Vicious circles" of glioblastoma tumors: vascularization and invasiveness].

  2012cited by this paper
• Oncolytic Virus Therapy for Glioblastoma Multiforme: Concepts and Candidates

  2012cited by this paper
• An anti-transferrin receptor antibody enhanced the growth inhibitory effects of chemotherapeutic drugs on human glioma cells.

  2011cited by this paper
• Expression of Nogo-66 receptor in human astrocytoma is correlated with tumor malignancy

  2011cited by this paper
• MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism.

  2011cited by this paper
• Chemokine receptor CXCR3 promotes growth of glioma.

  2011cited by this paper
• Oncolytic vaccinia virus for the treatment of cancer

  2011cited by this paper
• Novel diagnostic and therapeutic approaches to malignant glioma.

  2011cited by this paper
• Molecular diagnostics of gliomas: the clinical perspective

  2010cited by this paper
• MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

  2010cited by this paper
• Calcitonin Receptor Expression in Embryonic, Foetal and Adult Tissues: Developmental and Pathophysiological Implications

  2010cited by this paper
• The Utility and Limitations of Neurosphere Assay, CD133 Immunophenotyping and Side Population Assay in Glioma Stem Cell Research

  2010cited by this paper
• Glioma Diagnosis: Immunohistochemistry and Beyond

  2010cited by this paper
• Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

  2010cited by this paper
• Differential Distribution of erbB Receptors in Human Glioblastoma Multiforme: Expression of erbB3 in CD133-Positive Putative Cancer Stem Cells

  2010cited by this paper
• Oncolytic parvoviruses as cancer therapeutics.

  2010cited by this paper
• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• Attenuated AMPA Receptor Expression Allows Glioblastoma Cell Survival in Glutamate-Rich Environment

  2009cited by this paper
• Oncolytic viral therapy of malignant glioma

  2009cited by this paper
• AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrix.

  2009cited by this paper
• Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL

  2009cited by this paper
• Adenoviral virotherapy for malignant brain tumors

  2009cited by this paper
• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

  2009cited by this paper
• Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas.

  2009cited by this paper
• A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication.

  2008cited by this paper
• Identification of Formyl Peptides from Listeria monocytogenes and Staphylococcus aureus as Potent Chemoattractants for Mouse Neutrophils1

  2008cited by this paper
• A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas.

  2008cited by this paper
• Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands.

  2008cited by this paper
• Receptor "hijacking" by malignant glioma cells: a tactic for tumor progression.

  2008cited by this paper
• Nogo-A and Myelin-Associated Glycoprotein Differently Regulate Oligodendrocyte Maturation and Myelin Formation

  2008cited by this paper
• The role of CXC chemokines and their receptors in cancer.

  2008cited by this paper
• Chemokine production and chemokine receptor expression by human glioma cells: role of CXCL10 in tumour cell proliferation.

  2008cited by this paper
• Nogo-A is a Reliable Oligodendroglial Marker in Adult Human and Mouse CNS and in Demyelinated Lesions

  2007cited by this paper
• Low HER2-expressing glioblastomas are more often secondary to anaplastic transformation of low-grade glioma

  2007cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR

  2007cited by this paper
• WHO classification of tumours of the central nervous system

  2007cited by this paper
• Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.

  2007cited by this paper
• Dinucleotide Phosphate Oxidase Activation of Nicotinamide Adenine and Rapid phox uced Phosphorylation of p47 Formyl-Methionyl-Leucyl-Phenylalanine-IndActivation Loop Phosphorylation in d A Critical Role of Protein Kinase C

  2007cited by this paper
• Expression of stem cell markers in human astrocytomas of different WHO grades

  2007cited by this paper
• Activated MEK Suppresses Activation of PKR and Enables Efficient Replication and In Vivo Oncolysis by Δγ134.5 Mutants of Herpes Simplex Virus 1

  2006cited by this paper
• Comparative analysis of NeuN immunoreactivity in primary brain tumours: conclusions for rational use in diagnostic histopathology

  2006cited by this paper
• Variable Deficiencies in the Interferon Response Enhance Susceptibility to Vesicular Stomatitis Virus Oncolytic Actions in Glioblastoma Cells but Not in Normal Human Glial Cells

  2006cited by this paper
• Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1.

  2006cited by this paper
• Epidermal Growth Factor Receptor–Mediated Signal Transduction in the Development and Therapy of Gliomas

  2006cited by this paper
• Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration.

  2006cited by this paper
• A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.

  2006cited by this paper
• IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis.

  2006cited by this paper
• Increasing of HER2 Membranar Density in Human Glioblastoma U251MG Cell Line Established in a New Nude Mice Model

  2006cited by this paper
• Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor.

  2006cited by this paper
• IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis

  2006cited by this paper
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

  2006cited by this paper
• Rescue and propagation of fully retargeted oncolytic measles viruses

  2005cited by this paper
• The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes*

  2005cited by this paper
• Amplification and differential expression of members of theerbB-gene family in human glioblastoma

  2005cited by this paper
• EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme

  2005cited by this paper
• Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.

  2005cited by this paper
• Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification

  2005cited by this paper
• Human mitochondria‐derived N‐formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes‐derived peptides preferentially activate FPR

  2005cited by this paper
• AC133/CD133/Prominin-1.

  2005cited by this paper
• LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex

  2004cited by this paper
• Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier

  2004cited by this paper
• Identification of Neutrophil Granule Protein Cathepsin G as a Novel Chemotactic Agonist for the G Protein-Coupled Formyl Peptide Receptor 12

  2004cited by this paper
• The immunohistochemical expression of calcitonin receptor-like receptor (CRLR) in human gliomas

  2004cited by this paper
• Poliovirus receptor CD155-targeted oncolysis of glioma.

  2004cited by this paper
• Recombinant humanised anti-HER2/neu antibody (Herceptin®) induces cellular death of glioblastomas

  2004cited by this paper
• Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer

  2004cited by this paper
• EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma

  2004cited by this paper
• Interferon-beta gene therapy for cancer: basic research to clinical application.

  2004cited by this paper
• lnterferon‐β gene therapy for cancer: Basic research to clinical application

  2004cited by this paper
• The role of epidermal growth factor and its receptors in mammalian CNS.

  2004cited by this paper
• Epidermal growth factor receptor family (EGFR, ErbB2–4) in gliomas and meningiomas

  2004cited by this paper
• Neurobiology: At the root of brain cancer

  2004cited by this paper
• Radiation-induced activation of a common variant of EGFR confers enhanced radioresistance.

  2004cited by this paper
• A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model.

  2004cited by this paper
• Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4.

  2004cited by this paper
• Nogo‐66 and myelin‐associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo‐66 receptor expressing human glioma cells

  2004cited by this paper
• Gene Expression Profiling of Gliomas Strongly Predicts Survival

  2004cited by this paper
• p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies

  2004cited by this paper
• Oncolytic parvovirus H1 induces release of heat-shock protein HSP72 in susceptible human tumor cells but may not affect primary immune cells

  2003cited by this paper
• Regulatory approvals of pediatric oncology drugs: previous experience and new initiatives.

  2003cited by this paper
• Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf-CRM107) for Therapy of Malignant Gliomas

  2003cited by this paper
• Diphtheria toxin-epidermal growth factor fusion protein and Pseudomonas exotoxin-interleukin 13 fusion protein exert synergistic toxicity against human glioblastoma multiforme cells.

  2003cited by this paper
• Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway.

  2003cited by this paper
• Clinical Trials of Adenoviruses in Brain Tumors: A Review of Ad-p53 and Oncolytic Adenoviruses

  2003cited by this paper
• Role of Her-2/neu Overexpression and Clinical Determinants of Early Mortality in Glioblastoma Multiforme

  2003cited by this paper
• Genes and pathways driving glioblastomas in humans and murine disease models

  2003cited by this paper
• Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results.

  2003cited by this paper
• Functional Activation of the Formyl Peptide Receptor by a New Endogenous Ligand in Human Lung A549 Cells1

  2002cited by this paper
• IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.

  2002cited by this paper
• Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells.

  2002cited by this paper

• Practical and translational therapeutic elements for GBM therapy.

  2026cites this paper
• The Correlation Patterns of miRNA Expression with Targeted mRNA Transcripts in Glioma Patients with Wild-Type and Mutated Isocitrate Dehydrogenase (IDH) Genotypes

  2024cites this paper